Cannabis for peripheral neuropathy: The good, the bad, and the unknown is organized by Cleveland Clinic Center for Continuing Education and will be held from Dec 01, 2018 - Nov 30, 2019. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.

Target Audience
Directed to practitioners in pain management, neurology, palliative medicine, endocrinology, psychiatry/psychology, and geriatrics.

Even where it is legal, doctors should recommend it only after careful consideration.

Learning Objective
Readers will assess the possible benefits and risks of cannabis treatment for patients with peripheral neuropathy.

Intended Audience


Activity Payment Details

Activity Fee : NA

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


Cleveland Clinic Center for Continuing Education

View Organizer Details


216.444.9990, 216.448.8710